These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33493578)

  • 1. Use of ambulatory glucose monitoring and analysis of ambulatory glucose profile in clinical practice for diabetes management; a position statement of the Arab Society of Paediatric Endocrinology and diabetes.
    Deeb A; Muammar T; Alsaffar H; Sedaghat S; Al Hassani N; Odeh R; Alkhayyat H; Al Sinani A; Attia N; Adhami S; Elbarbary N
    Diabetes Res Clin Pract; 2021 Mar; 173():108671. PubMed ID: 33493578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-monitoring of blood glucose measurements and glycaemic control in a managed care paediatric type 1 diabetes practice.
    Davey B; Segal DG
    S Afr Med J; 2015 Apr; 105(5):405-7. PubMed ID: 26242666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED.
    Scaramuzza A; Cherubini V; Tumini S; Bonfanti R; Buono P; Cardella F; d'Annunzio G; Frongia AP; Lombardo F; Monciotti AC; Rabbone I; Schiaffini R; Toni S; Zucchini S; Frontino G; Iafusco D;
    Acta Diabetol; 2014 Apr; 51(2):173-84. PubMed ID: 24162715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term glucose-lowering effect of intermittently scanned continuous glucose monitoring for type 1 diabetes patients in poor glycaemic control from Region North Denmark: An observational real-world cohort study.
    Jensen MH; Cichosz SL; Gustenhoff P; Nikontovic A; Hejlesen O; Vestergaard P
    PLoS One; 2022; 17(10):e0274626. PubMed ID: 36240184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
    Moser O; Riddell MC; Eckstein ML; Adolfsson P; Rabasa-Lhoret R; van den Boom L; Gillard P; Nørgaard K; Oliver NS; Zaharieva DP; Battelino T; de Beaufort C; Bergenstal RM; Buckingham B; Cengiz E; Deeb A; Heise T; Heller S; Kowalski AJ; Leelarathna L; Mathieu C; Stettler C; Tauschmann M; Thabit H; Wilmot EG; Sourij H; Smart CE; Jacobs PG; Bracken RM; Mader JK
    Diabetologia; 2020 Dec; 63(12):2501-2520. PubMed ID: 33047169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of diabetes during Ramadan fasting in children and adolescents: A survey of physicians' perceptions and practices in the Arab Society for Paediatric Endocrinology and Diabetes (ASPED) countries.
    Elbarbary N; Deeb A; Habeb A; Beshyah SA
    Diabetes Res Clin Pract; 2019 Apr; 150():274-281. PubMed ID: 30629966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.
    Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
    Lancet; 2021 Jun; 397(10291):2275-2283. PubMed ID: 34089660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
    Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal T; Raimond L; Vistisen D; Nørgaard K
    Diabetologia; 2021 Dec; 64(12):2713-2724. PubMed ID: 34495375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes and High-Risk Glycemic Control: A Randomized Controlled Trial.
    Boucher SE; Gray AR; Wiltshire EJ; de Bock MI; Galland BC; Tomlinson PA; Rayns JA; MacKenzie KE; Chan H; Rose S; Wheeler BJ
    Diabetes Care; 2020 Oct; 43(10):2388-2395. PubMed ID: 32788281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Initiation of Intermittently Scanned Continuous Glucose Monitoring in a Pediatric Population With Type 1 Diabetes: A Real World Study.
    Franceschi R; Cauvin V; Stefani L; Berchielli F; Soffiati M; Maines E
    Front Endocrinol (Lausanne); 2022; 13():907517. PubMed ID: 35784525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes-Extension phase outcomes following a 6-month randomized control trial.
    Rose S; Styles SE; Wiltshire EJ; Stanley J; Galland BC; de Bock MI; Tomlinson PA; Rayns JA; MacKenzie KE; Wheeler BJ
    Diabet Med; 2022 May; 39(5):e14756. PubMed ID: 34862661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus.
    Lin R; Brown F; James S; Jones J; Ekinci E
    Diabet Med; 2021 May; 38(5):e14528. PubMed ID: 33496979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expert Panel Recommendations for Use of Standardized Glucose Reporting System Based on Standardized Glucometrics Plus Visual Ambulatory Glucose Profile (AGP) Data in Clinical Practice.
    Dagdelen S; Deyneli O; Dinccag N; Ilkova H; Osar Siva Z; Yetkin I; Yilmaz T
    Front Endocrinol (Lausanne); 2021; 12():663222. PubMed ID: 35140679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittently scanned continuous glucose monitoring is associated with high satisfaction but increased HbA1c and weight in well-controlled youth with type 1 diabetes.
    Charleer S; Gillard P; Vandoorne E; Cammaerts K; Mathieu C; Casteels K
    Pediatr Diabetes; 2020 Dec; 21(8):1465-1474. PubMed ID: 32981187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of paediatric type 1 diabetes.
    Marks BE; Wolfsdorf JI
    Curr Opin Pediatr; 2022 Aug; 34(4):391-399. PubMed ID: 35836398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of intermittently scanned continuous glucose monitoring on quality of life and glycaemic control in persons with type 1 diabetes: A 12-month follow-up study in real life.
    Duarte DB; Fonseca L; Santos T; Silva VB; Puga FM; Saraiva M; Silva IL; Teixeira S; Vilaverde J; Cardoso MH
    Diabetes Metab Syndr; 2022 Jun; 16(6):102509. PubMed ID: 35598543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the impact of Ramadan fasting on ambulatory glucose profile among patients with type 1 diabetes using Flash Glucose Monitoring System: A comparative study.
    Al Hayek AA; Robert AA; Al Dawish MA
    Diabetes Metab Syndr; 2022 Apr; 16(4):102472. PubMed ID: 35366597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Recommendations for the Use of the Ambulatory Glucose Profile in Diabetes Care.
    Kröger J; Reichel A; Siegmund T; Ziegler R
    J Diabetes Sci Technol; 2020 May; 14(3):586-594. PubMed ID: 31718268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes Canada Position Statement for People With Types 1 and 2 Diabetes Who Fast During Ramadan.
    Bajaj HS; Abouhassan T; Ahsan MR; Arnaout A; Hassanein M; Houlden RL; Khan T; Khandwala H; Verma S
    Can J Diabetes; 2019 Feb; 43(1):3-12. PubMed ID: 29804943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.